Overview
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine
Current Appointments & Affiliations
Professor of Medicine
·
2021 - Present
Medicine, Cardiology,
Medicine
Member in the Duke Clinical Research Institute
·
2009 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Catheter ablation in patients with atrial fibrillation and cancer: a systematic review and updated meta-analysis.
Journal Article J Interv Card Electrophysiol · April 2026 BACKGROUND: Atrial fibrillation (AF) is common in cancer patients, and catheter ablation (CA) is a treatment option. However, outcomes of CA in cancer patients remain unclear. OBJECTIVES: To evaluate the outcomes of CA for AF in patients with a current or ... Full text Link to item CiteCoevolutionary analysis of evidence and recommendations in STEMI clinical practice guidelines: A 33-year meta-research study of ACC, AHA, and ESC.
Journal Article Am Heart J · April 2026 BACKGROUND: ST-Segment Elevation Myocardial Infarction (STEMI) is considered the main cause of mortality and morbidity for decades globally. Regularly, cardiology-related medical organizations publish clinical practice guidelines (CPGs) to support healthca ... Full text Link to item CiteDisparities in access and three-year survival of patients with ST-elevation myocardial infarction treated in percutaneous coronary intervention-capable hospitals within the Brazilian public and private healthcare systems: The VICTIM extended registry.
Journal Article Public Health · April 2026 OBJECTIVES: Disparities in the management and outcomes of ST-segment elevation myocardial infarction (STEMI) between public and private healthcare sectors are a critical concern in middle-income countries. In Brazil, national data on long-term survival and ... Full text Link to item CiteRecent Grants
Protocol CS12_CEC
Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2025 - 2029A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2029Priovant BREPO
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2029View All Grants
Education
Duke University, School of Medicine ·
2009
M.H.S.
Paulista Medical School, University of Sao Paulo (Brazil) ·
2006
Ph.D.
University of Santo Amaro (Brazil) ·
2001
M.D.